A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin
Part of paid clinical trials in Manhattan Beach, California.
- Sponsor
- Galderma R&D
- Study ID
- NCT07398989
- Phase
- PHASE4
- Status
- Completed
Conditions
- Aging Skin
- Crepey Skin
- Photo-aged Skin
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cetaphil — DRUGSubjects will apply Cetaphil Hydrating and Firming Cream Skin Activator to the knees, thighs, hands, and all of the body at least twice daily. Subjects will use Cetaphil Daily Facial Moisturizer SPF 35 as needed.
Study Details
Subjects having mild-to-moderate crepiness, photodamage, and loss of firmness will apply a topical skincare regimen to the knees, thighs, hands, and all over the body. Evaluations of the regimen's efficacy will be conducted at 4 weeks, 8 weeks, and 12 weeks post-baseline.
Key Dates
- Start date
- Aug 12, 2025
- Status verified
- Apr 2026
- Primary completion
- Mar 25, 2026
- Completion
- Mar 25, 2026
Study Design
- Enrollment
- 32 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Skincare Product TreatmentSubjects will apply topical skincare products to the body.
Primary Outcome Measure
Change of clinical grading compared to baseline [ Time Frame: Baseline, Week 4, Week 8, Week 12 ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ablon Skin Institute & Research Center | Manhattan Beach | California | 90266 | - |
| Clinical Research Center of the Carolinas | Charleston | South Carolina | 29407 | - |
Find similar trials in Manhattan Beach, CA
Related Studies
- A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive ImagingRecruiting · Galderma R&D · New York, New York